Bristol-Myers Squibb Company (BMY) Financial Statements

Comprehensive financial analysis for BMY including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed BMY financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):19.35

Forward P/E:8.00

EPS (TTM):$2.49

Enterprise Value:$136.04B

Profitability Ratios

Profit Margin:10.58%

Return on Equity:29.32%

Return on Assets:8.34%

Operating Margin:33.66%

Financial Health

Current Ratio:1.21

Quick Ratio:1.04

Debt to Equity:291.55

Beta (5Y):0.37

Revenue and Profit Trends

Growth Metrics

Revenue Growth

0.60%

Earnings Growth

-22.80%

Revenue Per Share

$23.49

Performance Metrics

Profit Margin Trend

10.58%

Return on Equity

29.32%

Return on Assets

8.34%

Analyst Insights

Price Targets

Average Target

$53.00

High Target

$68.00

Low Target

$34.00

Analyst Recommendations

Recommendation

Hold

Analyst Coverage

21 Analysts

Upside Potential

+10.0%